Sectors
CRL
Charles River Laboratories International, Inc.
306.24
1 x 304.81
1 x 308.35
bid
ask
+
4.24
1.40%
10 @ 04:01 AM
308.59 +2.35 (0.77%)
| Ytd | 53.52% | |
| 1y | 75.04% |
295.51
day range
309.48
146.20
52 week range
333.30
| Open | 301.81 | Prev Close | 302.00 | Low | 295.51 | High | 309.48 | Mkt Cap | 14.75B |
| Vol | 919.49K | Avg Vol | 945.61K | EPS | -4.80 | P/E | N/A | Forward P/E | 24.02 |
| Beta | 1.40 | Short Ratio | 3.02 | Inst. Own | 122.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 288.19 | 200-d Avg | 214.60 | 1yr Est | 315.53 |
| Income Statement | |||
| Total Revenue | 1.00B | ||
| Revenues (USD) | 1.00B | ||
| Cost of Revenue | 640.70M | ||
| Gross Profit | 363.37M | ||
| Operating Expenses | 243.49M | ||
| Selling, General and Administrative Expense | 228.90M | ||
| Operating Income | 119.89M | ||
| Interest Expense | 30.34M | ||
| Income Tax Expense | 53.93M | ||
| Net Income | -1.48M | ||
| Net Income Common Stock | -1.48M | ||
| Net Income Common Stock (USD) | -1.48M | ||
| Consolidated Income | -760.00K | ||
| Net Income to Non-Controlling Interests | 722.00K | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | 82.79M | ||
| Earning Before Interest & Taxes (USD) | 82.79M | ||
| Weighted Average Shares | 48.02M | ||
| Weighted Average Shares Diluted | 48.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 192.03M | ||
| Cash and Equivalents (USD) | 192.03M | ||
| Investments | 206.47M | ||
| Investments Non-Current | 206.47M | ||
| Trade and Non-Trade Receivables | 711.76M | ||
| Current Assets | 1.53B | ||
| Property, Plant & Equipment Net | 1.83B | ||
| Total Assets | 7.53B | ||
| Total Debt | 3.03B | ||
| Current Liabilities | 1.13B | ||
| Debt Non-Current | 3.03B | ||
| Total Liabilities | 4.64B | ||
| Accumulated Retained Earnings (Deficit) | 1.37B | ||
| Accumulated Other Comprehensive Income | -195.99M | ||
| Shareholders Equity | 2.84B | ||
| Shareholders Equity (USD) | 2.84B | ||
| Assets Non-Current | 6.00B | ||
| Total Debt (USD) | 3.03B | ||
| Deferred Revenue | 203.04M | ||
| Goodwill and Intangible Assets | 3.33B | ||
| Inventory | 346.26M | ||
| Liabilities Non-Current | 3.51B | ||
| Trade and Non-Trade Payables | 140.98M | ||
| Tax Assets | 53.83M | ||
| Tax Liabilities | 78.67M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 67.29M | ||
| Net Cash Flow from Financing | -164.66M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 42.38M | ||
| Capital Expenditure | -31.10M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 50.91M | ||
| Issuance (Purchase) of Equity Shares | -115.20M | ||
| Issuance (Repayment) of Debt Securities | -37.45M | ||
| Net Cash Flow from Investing | 28.10M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 8.14M | ||
| Net Cash Flow from Operations | 179.73M | ||
| Effect of Exchange Rate Changes on Cash | -781.00K | ||
| Share Based Compensation | 19.78M | ||